Medical Devices Mexico

Mexico Preeclampsia Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Mexico Preeclampsia Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Mexico · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $21.8 Mn Placeholder estimate
Estimate 2025 $23.4 Mn 1.5% of the global market
Projected 2034 $44.1 Mn 88.5% Adds $20.7 Mn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 28% of 173 Medical Devices markets here
Key players 5
  • Mexico is 1.46% of the global market.
  • In Latin America, the largest is Brazil at $43.0 Mn.
  • Fastest growing: Brazil at 7.7% a year.
  • Mexico ranks 3rd of 3 by size in Latin America.

Market size projection

Mexico

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$20.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Preeclampsia Diagnostics Market market size by year, Mexico
YearMarket sizeChange that yearSince 2025
2024 (estimate) $21.8 Mn — —
2025 (base) $23.4 Mn +$1.6 Mn —
2026 (forecast) $25.1 Mn +$1.7 Mn +7.3%
2027 (forecast) $26.9 Mn +$1.8 Mn +15.1%
2028 (forecast) $28.9 Mn +$2.0 Mn +23.5%
2029 (forecast) $31.0 Mn +$2.1 Mn +32.6%
2030 (forecast) $33.2 Mn +$2.3 Mn +42.2%
2031 (forecast) $35.7 Mn +$2.4 Mn +52.6%
2032 (forecast) $38.3 Mn +$2.6 Mn +63.8%
2033 (forecast) $41.1 Mn +$2.8 Mn +75.7%
2034 (forecast) $44.1 Mn +$3.0 Mn +88.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.60 Bn
  2. US $724.9 Mn
  3. North America $725.3 Mn
  4. APAC $325.9 Mn
  5. Europe $285.6 Mn
  6. Canada $131.7 Mn
  7. China $114.6 Mn
  8. Japan $107.0 Mn
  9. Latin America $66.5 Mn
  10. Middle East $64.3 Mn
  11. Germany $56.7 Mn
  12. Brazil $43.0 Mn
  13. France $41.0 Mn
  14. Italy $38.1 Mn
  15. UK $35.6 Mn
  16. Spain $34.6 Mn
  17. India $33.5 Mn
  18. Ecuador $30.7 Mn
  19. Saudi Arabia $28.8 Mn
  20. Mexico (this report) $23.4 Mn
  21. Africa $23.1 Mn
  22. Russia $18.2 Mn
  23. New Zealand $17.1 Mn
  24. Australia $17.6 Mn
  25. South Africa $9.6 Mn
  26. UAE $7.4 Mn
  27. Egypt $5.1 Mn
  28. Philippines $3.9 Mn
  29. Malaysia $2.4 Mn
  30. Hong Kong $2.2 Mn
  31. Singapore $2.2 Mn
  32. Thailand $1.7 Mn
  33. Kenya $1.3 Mn

Report snapshot

Mexico Preeclampsia Diagnostics Market Analysis at a glance
Market size, 2025$23.4 Mn placeholder estimate
Forecast, 2034$44.1 Mn placeholder estimate
Growth (CAGR), 2025–20347.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, use and end user (see all)
Key playersRoche Diagnostics, Thermo Fisher Scientific Inc., Perkin Elmer, Siemens Healthineers, Quidel Corporation (see all)
Regulator in MexicoCOFEPRISSource: COFEPRIS. Checked 14 Nov 2026.
Active clinical trials2 in MexicoSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Mexico. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Mexico Preeclampsia Diagnostics Market Analysis Executive Summary

Preeclampsia diagnostics are blood tests and monitoring tools that predict or detect dangerous high blood pressure in pregnancy.

Key segments of the preeclampsia Diagnostics market include test (sFlt-1/PlGF Ratio Tests, PlGF Tests and Blood Pressure Monitoring) and use (Screening, Diagnosis and Prognosis).

Bar chart: Mexico Preeclampsia Diagnostics market size, 2024–2034, placeholder estimates. $21.8 Mn in 2024, $23.4 Mn in 2025 and $44.1 Mn in 2034, 7.3% CAGR.
Mexico Preeclampsia Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Mexico Preeclampsia Diagnostics Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the preeclampsia Diagnostics market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the preeclampsia Diagnostics market.

Competitive Landscape for Preeclampsia Diagnostics Market in Mexico

The preeclampsia Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Preeclampsia Diagnostics Market in Mexico

Preeclampsia Diagnostics in Mexico: rules, payment and research

Medical devices need a sanitary registration from COFEPRIS before sale.⁠[1] Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security.⁠[2] ClinicalTrials.gov lists 2 studies on Preeclampsia Diagnostics that are recruiting, active or about to start in Mexico.⁠[3]

[1] COFEPRIS. Checked 14 Nov 2026.

[2] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Mexico. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how preeclampsia Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Mexico.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Preeclampsia Diagnostics right now, from free public sources.

Latest research 7,556 papers since 2021 (worldwide)

  1. Artificial Intelligence in Obstetrics and Prenatal Medicine: Current Evidence, Clinical Validation and Implementation. Geburtshilfe und Frauenheilkunde, 2026
  2. Skinfolds in nulliparous women and their association with pregnancy complications: a multicenter cohort study in Brazil. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2026
  3. Perinatal outcomes after implementation of a blended virtual and in-person prenatal care model in integrated healthcare systems. Pregnancy (Hoboken, N.J.), 2026
  4. Screening of oxidative stress-related signature genes and construction of an interpretable discriminant model for preeclampsia. Frontiers in genetics, 2026
  5. Blood pressure changes across pregnancy and postpartum: from physiological adaptations to pathological deviations. Frontiers in cardiovascular medicine, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Preeclampsia Diagnostics in context

Mexico compared

  • Health spending per person: 761 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.59 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 8.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 4 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Preeclampsia Diagnostics market in Mexico?
Placeholder estimate: about $23.4 Mn in 2025, rising to about $44.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Preeclampsia Diagnostics market in Mexico growing?
Placeholder estimate: about 7.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Preeclampsia Diagnostics market report cover?
The report splits the market by test (sFlt-1/PlGF Ratio Tests, PlGF Tests, Blood Pressure Monitoring, Urine Protein Tests), use (Screening, Diagnosis, Prognosis) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Preeclampsia Diagnostics market?
Key players include Roche Diagnostics, Thermo Fisher Scientific Inc., Perkin Elmer, Siemens Healthineers and Quidel Corporation.
What is driving the Preeclampsia Diagnostics market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.
Who regulates Preeclampsia Diagnostics in Mexico?
Medical devices need a sanitary registration from COFEPRIS before sale. Source: COFEPRIS. Checked 14 Nov 2026.
How is healthcare paid for in Mexico?
Public care comes through IMSS for formal workers, ISSSTE for public employees, and IMSS-Bienestar for people without social security. Source: Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
How many clinical trials on Preeclampsia Diagnostics are running in Mexico?
2 studies are recruiting, active or about to start in Mexico, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Mexico. Retrieved 12 Nov 2026.
How much research is published on Preeclampsia Diagnostics?
PubMed lists 7,556 papers on Preeclampsia Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Preeclampsia Diagnostics in Mexico? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Mexico

See all
Same topic, other categories

Related on maternal and diagnostics and lab testing

See the topic